IKDCs or B220+ NK cells are pre-mNK cells

Laurence Zitvogel; Franck Housseau

doi:10.1182/blood-2012-03-415026

IKDCs or B220⁺ NK cells are pre-mNK cells

Laurence Zitvogel, Franck Housseau

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

12 Scopus citations

Abstract

The cell lineage origin of interferon-producing killer dendritic cells (IKDCs) has been challenged since 2006 when the unique capacity of these cells to accumulate in tumors and mediate remarkable antitumor effects was first described.^1-4 In this issue of Blood, Guimont-Desrochers et al redefine B220⁺ NK cells as a novel intermediate in NK-cell differentiation preceding the acquisition of CD27.

Original language	English (US)
Pages (from-to)	4345-4346
Number of pages	2
Journal	Blood
Volume	119
Issue number	19
DOIs	https://doi.org/10.1182/blood-2012-03-415026
State	Published - May 10 2012

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2012-03-415026

Cite this

@article{e607feb01bc34b7dba3e57b4db45d14a,

title = "IKDCs or B220+ NK cells are pre-mNK cells",

abstract = "The cell lineage origin of interferon-producing killer dendritic cells (IKDCs) has been challenged since 2006 when the unique capacity of these cells to accumulate in tumors and mediate remarkable antitumor effects was first described.1-4 In this issue of Blood, Guimont-Desrochers et al redefine B220+ NK cells as a novel intermediate in NK-cell differentiation preceding the acquisition of CD27.",

author = "Laurence Zitvogel and Franck Housseau",

year = "2012",

month = may,

day = "10",

doi = "10.1182/blood-2012-03-415026",

language = "English (US)",

volume = "119",

pages = "4345--4346",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "19",

}

TY - JOUR

T1 - IKDCs or B220+ NK cells are pre-mNK cells

AU - Zitvogel, Laurence

AU - Housseau, Franck

PY - 2012/5/10

Y1 - 2012/5/10

N2 - The cell lineage origin of interferon-producing killer dendritic cells (IKDCs) has been challenged since 2006 when the unique capacity of these cells to accumulate in tumors and mediate remarkable antitumor effects was first described.1-4 In this issue of Blood, Guimont-Desrochers et al redefine B220+ NK cells as a novel intermediate in NK-cell differentiation preceding the acquisition of CD27.

AB - The cell lineage origin of interferon-producing killer dendritic cells (IKDCs) has been challenged since 2006 when the unique capacity of these cells to accumulate in tumors and mediate remarkable antitumor effects was first described.1-4 In this issue of Blood, Guimont-Desrochers et al redefine B220+ NK cells as a novel intermediate in NK-cell differentiation preceding the acquisition of CD27.

UR - http://www.scopus.com/inward/record.url?scp=84860907999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860907999&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-03-415026

DO - 10.1182/blood-2012-03-415026

M3 - Comment/debate

C2 - 22577157

AN - SCOPUS:84860907999

SN - 0006-4971

VL - 119

SP - 4345

EP - 4346

JO - Blood

JF - Blood

IS - 19

ER -

IKDCs or B220⁺ NK cells are pre-mNK cells

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this